VRTX Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
VRTX net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 139 observations from Dec 31, 1991 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 21.1018% | |
| 538.6996% | |
| 838.0881% | |
| 865.965% | |
| 842.5189% | |
| -124.6032% | |
| -114.7972% | |
| -113.8283% | |
| -114.5591% | |
| 23.3058% | |
| 8.9585% | |
| 6.0033% | |
| 5.3299% | |
| 32.9919% | |
| 41.8391% | |
| 50.4104% | |
| 60.3982% | |
| -11.2591% | |
| -13.6285% | |
| -19.1219% | |
| -4.2815% | |
| 82.8032% | |
| 130.4235% | |
| 25.4926% | |
| -6.0739% | |
| -29.8957% | |
| -43.8785% | |
| 231.3644% | |
| 433.3585% | |
| 853.6946% | |
| 695.8343% | |
| 230.5591% | |
| 61.7073% | |
| 29.6303% | |
| 329.013% | |
| 187.5781% | |
| 192.7891% | |
| 143.4599% | |
| 79.3856% | |
| 66.0969% | |
| 62.2952% | |
| 43.0768% | |
| 24.4315% | |
| -27.365% | |
| -55.6503% | |
| -90.7379% | |
| -65.9596% | |
| 8.4605% | |
| 5.4509% | |
| 27.0757% | |
| -315.7831% | |
| -542.6428% | |
| -222.7545% | |
| -270.436% | |
| -461.9125% | |
| 141.2817% | |
| 154.9547% | |
| 138.8346% | |
| 103.919% | |
| 57.7765% | |
| -9.8039% | |
| -18.7156% | |
| -17.5104% | |
| -17.0982% | |
| -11.0731% | |
| -22.4952% | |
| -39.6491% | |
| -55.1978% | |
| -59.4558% | |
| -29.4228% | |
| -17.5251% | |
| -21.1487% | |
| -36.9607% | |
| -71.2211% | |
| -89.1233% | |
| -52.9194% | |
| -13.1133% | |
| -13.7693% | |
| -1.7078% | |
| -4.6252% | |
| -46.7605% | |
| -22.4331% | |
| -22.3583% | |
| -26.4718% | |
| 21.1678% | |
| 20.1961% | |
| -8.9173% | |
| -14.4874% | |
| -133.8565% | |
| -224.045% | |
| -40.5216% | |
| -80.0672% | |
| 2.7892% | |
| 21.8796% | |
| -52.5255% | |
| -0.7436% | |
| -63.4711% | |
| -160.7804% | |
| -79.5728% | |
| -196.6185% |
Compare net income growth
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) net income growth
- Johnson & Johnson (JNJ) net income growth
- AbbVie (ABBV) net income growth
- UnitedHealth Group (UNH) net income growth
- Merck & Co. (MRK) net income growth
- Thermo Fisher Scientific (TMO) net income growth
- Amgen (AMGN) net income growth
- Gilead Sciences (GILD) net income growth
Compare all covered stocks by net income growth →
All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics